The Patent Trolls Are Coming...To Medtech
Executive Summary
For years medical device makers have largely avoided one of the technology world’s biggest headaches: patent “troll” litigation, but that’s about to change. What medtech needs to do to fight the trolls.
You may also be interested in...
Patent Troll Legislation Gets Attention At Senate Hearing
Biotechnology Industry Organization throws support behind Senate bill’s revisions to the inter partes review process, argues against provisions in House measure.
The Business Case For Post-Grant Patent Review
Counsels’ view of what inter parte reviews and other new procedures introduced by the America Invents Act mean to the biopharma industry.
The Secret Weapons Of NPEs
Non-practicing entities have a few characteristics that create an uneven playing field in patent-infringement lawsuits.